IMS-088

N/A

Report date: 2025/01/26 19:07:17
NME

Base Information

Drug NameIMS-088
Drug Alias Namewithaferin analogs (ImStar Therapeutics)TDP-43 associated NF-kappa B activation inhibitor (ImStar)TANA inhibitor (ImStar)IMS-088
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImStar Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesImStar Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A